{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:57:59Z","timestamp":1793829479458,"version":"4.6.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-70453-9","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T13:09:02Z","timestamp":1773752942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Surface hydrophobicity and rigidity determines protein corona on orally delivered nanoparticles treating colitis"],"prefix":"10.1038","volume":"17","author":[{"given":"Jiawei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0395-0821","authenticated-orcid":false,"given":"Mingjie","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyun","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3616-8206","authenticated-orcid":false,"given":"Lian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3410-8602","authenticated-orcid":false,"given":"Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"70453_CR1","doi-asserted-by":"publisher","first-page":"114356","DOI":"10.1016\/j.addr.2022.114356","volume":"186","author":"Q Xiao","year":"2022","unstructured":"Xiao, Q. et al. The effects of protein corona on in vivo fate of nanocarriers. Adv. Drug Deliv. Rev. 186, 114356 (2022).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"70453_CR2","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41578-023-00552-2","volume":"8","author":"M Mahmoudi","year":"2023","unstructured":"Mahmoudi, M., Landry, M. P., Moore, A. & Coreas, R. The protein corona from nanomedicine to environmental science. Nat. Rev. Mater. 8, 422\u2013438 (2023).","journal-title":"Nat. Rev. Mater."},{"key":"70453_CR3","doi-asserted-by":"publisher","first-page":"7455","DOI":"10.1021\/acsnano.3c11315","volume":"18","author":"D Yang","year":"2024","unstructured":"Yang, D. et al. Protein coronas derived from mucus act as both spear and shield to regulate transferrin functionalized nanoparticle transcellular transport in enterocytes. ACS Nano 18, 7455\u20137472 (2024).","journal-title":"ACS Nano"},{"key":"70453_CR4","first-page":"401","volume":"17","author":"W Xu","year":"2022","unstructured":"Xu, W. et al. Changes in target ability of nanoparticles due to protein corona composition and disease state. Asian J. Pharm. Sci. 17, 401\u2013411 (2022).","journal-title":"Asian J. Pharm. Sci."},{"key":"70453_CR5","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1039\/C6BM00921B","volume":"5","author":"C Corbo","year":"2017","unstructured":"Corbo, C., Molinaro, R., Tabatabaei, M., Farokhzad, O. C. & Mahmoudi, M. Personalized protein corona on nanoparticles and its clinical implications. Biomater. Sci. 5, 378\u2013387 (2017).","journal-title":"Biomater. Sci."},{"key":"70453_CR6","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1002\/med.21767","volume":"41","author":"T Zhang","year":"2021","unstructured":"Zhang, T., Zhu, G., Lu, B., Qian, Z. & Peng, Q. Protein corona formed in the gastrointestinal tract and its impacts on oral delivery of nanoparticles. Med Res Rev. 41, 1835\u20131850 (2021).","journal-title":"Med Res Rev."},{"key":"70453_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jconrel.2024.02.020","volume":"368","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Lipid-mediated protein corona regulation with increased apolipoprotein AI recruitment for glioma targeting. J. Control Release 368, 42\u201351 (2024).","journal-title":"J. Control Release"},{"key":"70453_CR8","doi-asserted-by":"crossref","unstructured":"Pineiro-Alonso L., et al. Nanomedicine for targeting brain neurodegeneration: critical barriers and circadian rhythm considerations. Adv. Drug Deliv. Rev. 222, 115606 (2025).","DOI":"10.1016\/j.addr.2025.115606"},{"key":"70453_CR9","doi-asserted-by":"publisher","first-page":"65540","DOI":"10.1021\/acsami.4c14641","volume":"16","author":"Y Tang","year":"2024","unstructured":"Tang, Y. et al. Contribution of cancer-specific protein coronas to the pro-tumor effects of nanoplastics through enhanced cellular interactions. ACS Appl Mater. Interfaces 16, 65540\u201365552 (2024).","journal-title":"ACS Appl Mater. Interfaces"},{"key":"70453_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45254-7","volume":"15","author":"Y Miao","year":"2024","unstructured":"Miao, Y. et al. Regulating protein corona on nanovesicles by glycosylated polyhydroxy polymer modification for efficient drug delivery. Nat. Commun. 15, 1159 (2024).","journal-title":"Nat. Commun."},{"key":"70453_CR11","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1016\/j.apsb.2023.02.012","volume":"13","author":"J Wu","year":"2023","unstructured":"Wu, J. et al. Disease-specific protein corona formed in pathological intestine enhances the oral absorption of nanoparticles. Acta Pharm. Sin. B 13, 3876\u20133891 (2023).","journal-title":"Acta Pharm. Sin. B"},{"key":"70453_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jconrel.2022.05.055","volume":"348","author":"S Khan","year":"2022","unstructured":"Khan, S. et al. Artificial engineering of the protein corona at bio-nano interfaces for improved cancer-targeted nanotherapy. J. Control Release 348, 127\u2013147 (2022).","journal-title":"J. Control Release"},{"key":"70453_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2019.01.002","volume":"143","author":"Z Zhao","year":"2019","unstructured":"Zhao, Z., Ukidve, A., Krishnan, V. & Mitragotri, S. Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers. Adv. Drug Deliv. Rev. 143, 3\u201321 (2019).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"70453_CR14","doi-asserted-by":"publisher","first-page":"116627","DOI":"10.1016\/j.biopha.2024.116627","volume":"175","author":"T Zhao","year":"2024","unstructured":"Zhao, T. et al. Engineering the protein corona: strategies, effects, and future directions in nanoparticle therapeutics. Biomed. Pharmacother. 175, 116627 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"70453_CR15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41565-021-00924-1","volume":"16","author":"KE Wheeler","year":"2021","unstructured":"Wheeler, K. E. et al. Environmental dimensions of the protein corona. Nat. Nanotechnol. 16, 617\u2013629 (2021).","journal-title":"Nat. Nanotechnol."},{"key":"70453_CR16","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1021\/acs.nanolett.0c03756","volume":"21","author":"M Li","year":"2021","unstructured":"Li, M. et al. Brush conformation of polyethylene glycol determines the stealth effect of nanocarriers in the low protein adsorption regime. Nano Lett. 21, 1591\u20131598 (2021).","journal-title":"Nano Lett."},{"key":"70453_CR17","doi-asserted-by":"publisher","first-page":"20757","DOI":"10.1039\/D4RA03153A","volume":"14","author":"X Tian","year":"2024","unstructured":"Tian, X. & Yuan, Y. Impacts of polyethylene glycol (PEG) dispersity on protein adsorption, pharmacokinetics, and biodistribution of PEGylated gold nanoparticles. RSC Adv. 14, 20757\u201320764 (2024).","journal-title":"RSC Adv."},{"key":"70453_CR18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jcis.2021.12.044","volume":"610","author":"M Wen","year":"2022","unstructured":"Wen, M. et al. Interactions of cationic gold nanoclusters with serum proteins and effects on their cellular responses. J. Colloid Interface Sci. 610, 116\u2013125 (2022).","journal-title":"J. Colloid Interface Sci."},{"key":"70453_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31882-4","volume":"13","author":"M Li","year":"2022","unstructured":"Li, M. et al. Nanoparticle elasticity affects systemic circulation lifetime by modulating adsorption of apolipoprotein AI in corona formation. Nat. Commun. 13, 4137 (2022).","journal-title":"Nat. Commun."},{"key":"70453_CR20","doi-asserted-by":"publisher","first-page":"48284","DOI":"10.1021\/acsami.0c12341","volume":"12","author":"SM Pustulka","year":"2020","unstructured":"Pustulka, S. M., Ling, K., Pish, S. L. & Champion, J. A. Protein nanoparticle charge and hydrophobicity govern protein corona and macrophage uptake. ACS Appl Mater. Interfaces 12, 48284\u201348295 (2020).","journal-title":"ACS Appl Mater. Interfaces"},{"key":"70453_CR21","doi-asserted-by":"publisher","first-page":"14695","DOI":"10.1039\/D2NR03611H","volume":"14","author":"Y Arezki","year":"2022","unstructured":"Arezki, Y. et al. Surface charge influences protein corona, cell uptake and biological effects of carbon dots. Nanoscale 14, 14695\u201314710 (2022).","journal-title":"Nanoscale"},{"key":"70453_CR22","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1093\/ibd\/izab029","volume":"27","author":"S Dharmasiri","year":"2021","unstructured":"Dharmasiri, S. et al. Human intestinal macrophages are involved in the pathology of both ulcerative colitis and Crohn disease. Inflamm. Bowel Dis. 27, 1641\u20131652 (2021).","journal-title":"Inflamm. Bowel Dis."},{"key":"70453_CR23","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41575-019-0172-4","volume":"16","author":"YR Na","year":"2019","unstructured":"Na, Y. R., Stakenborg, M., Seok, S. H. & Matteoli, G. Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD. Nat. Rev. Gastroenterol. Hepatol. 16, 531\u2013543 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"70453_CR24","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41575-023-00769-0","volume":"20","author":"LM Hegarty","year":"2023","unstructured":"Hegarty, L. M., Jones, G.-R. & Bain, C. C. Macrophages in intestinal homeostasis and inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 20, 538\u2013553 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"70453_CR25","doi-asserted-by":"publisher","first-page":"2304002","DOI":"10.1002\/advs.202304002","volume":"10","author":"J Cheng","year":"2023","unstructured":"Cheng, J. et al. Macrophage-derived extracellular vesicles-coated palladium nanoformulations modulate inflammatory and immune homeostasis for targeting therapy of ulcerative colitis. Adv. Sci. 10, 2304002 (2023).","journal-title":"Adv. Sci."},{"key":"70453_CR26","doi-asserted-by":"publisher","first-page":"2307247","DOI":"10.1002\/smll.202307247","volume":"20","author":"L Ma","year":"2024","unstructured":"Ma, L. et al. Mulberry Leaf lipid nanoparticles: a naturally targeted CRISPR\/Cas9 oral delivery platform for alleviation of Colon diseases. Small 20, 2307247 (2024).","journal-title":"Small"},{"key":"70453_CR27","doi-asserted-by":"publisher","first-page":"eado6798","DOI":"10.1126\/sciadv.ado6798","volume":"10","author":"R Luo","year":"2024","unstructured":"Luo, R. et al. Oral microsphere formulation of M2 macrophage-mimetic Janus nanomotor for targeted therapy of ulcerative colitis. Sci. Adv. 10, eado6798 (2024).","journal-title":"Sci. Adv."},{"key":"70453_CR28","doi-asserted-by":"publisher","first-page":"121976","DOI":"10.1016\/j.biomaterials.2022.121976","volume":"293","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. Orally deliverable sequence-targeted astaxanthin nanoparticles for colitis alleviation. Biomaterials 293, 121976 (2023).","journal-title":"Biomaterials"},{"key":"70453_CR29","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1021\/acsnano.9b10195","volume":"14","author":"Kenry","year":"2020","unstructured":"Kenry et al. Mechanistic understanding of the biological responses to polymeric nanoparticles. ACS Nano 14, 4509\u20134522 (2020).","journal-title":"ACS Nano"},{"key":"70453_CR30","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1021\/acs.molpharmaceut.8b00713","volume":"15","author":"L Wu","year":"2018","unstructured":"Wu, L. et al. Transport mechanisms of butyrate modified nanoparticles: insight into \u201ceasy entry, hard transcytosis\u201d of active targeting system in oral administration. Mol. Pharm. 15, 4273\u20134283 (2018).","journal-title":"Mol. Pharm."},{"key":"70453_CR31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1021\/mp400493b","volume":"11","author":"X Zhu","year":"2014","unstructured":"Zhu, X. et al. Penetratin derivative-based nanocomplexes for enhanced intestinal insulin delivery. Mol. Pharm. 11, 317\u2013328 (2014).","journal-title":"Mol. Pharm."},{"key":"70453_CR32","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1021\/la902868g","volume":"26","author":"T Akagi","year":"2010","unstructured":"Akagi, T., Watanabe, K., Kim, H. & Akashi, M. Stabilization of polyion complex nanoparticles composed of poly (amino acid) using hydrophobic interactions. Langmuir 26, 2406\u20132413 (2010).","journal-title":"Langmuir"},{"key":"70453_CR33","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jhazmat.2012.02.043","volume":"215","author":"Y Xiao","year":"2012","unstructured":"Xiao, Y. & Wiesner, M. R. Characterization of surface hydrophobicity of engineered nanoparticles. J. Hazard Mater. 215, 146\u2013151 (2012).","journal-title":"J. Hazard Mater."},{"key":"70453_CR34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0168-3659(02)00127-X","volume":"82","author":"SK Sahoo","year":"2002","unstructured":"Sahoo, S. K., Panyam, J., Prabha, S. & Labhasetwar, V. Residual polyvinyl alcohol associated with poly (D, L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J. Control Release 82, 105\u2013114 (2002).","journal-title":"J. Control Release"},{"key":"70453_CR35","doi-asserted-by":"crossref","unstructured":"Liu X., et al. Harnessing surface hydrophilicity of inhalable nanoparticles for precision delivery of glucagon-like peptide-1 receptor agonists or anti-asthmatic therapeutics. ACS Nano (2025).","DOI":"10.1021\/acsnano.5c05745"},{"key":"70453_CR36","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jconrel.2024.01.044","volume":"367","author":"Y Yu","year":"2024","unstructured":"Yu, Y., Ni, M., Zheng, Y. & Huang, Y. Airway epithelial-targeted nanoparticle reverses asthma in inhalation therapy. J. Control Release 367, 223\u2013234 (2024).","journal-title":"J. Control Release"},{"key":"70453_CR37","doi-asserted-by":"crossref","unstructured":"Ni M. et al. Bioengineered milk-derived extracellular vesicles implementing high drug loading and membrane integrity for efficient oral drug delivery. Asian J. Pharm. Sci. 20, 101093 (2025).","DOI":"10.1016\/j.ajps.2025.101093"},{"key":"70453_CR38","doi-asserted-by":"publisher","first-page":"702173","DOI":"10.3389\/fbioe.2021.702173","volume":"9","author":"M Lin","year":"2021","unstructured":"Lin, M. et al. Lentinan-based oral nanoparticle loaded budesonide with macrophage-targeting ability for treatment of ulcerative colitis. Front Bioeng. Biotechnol. 9, 702173 (2021).","journal-title":"Front Bioeng. Biotechnol."},{"key":"70453_CR39","doi-asserted-by":"publisher","first-page":"eabj2372","DOI":"10.1126\/sciadv.abj2372","volume":"8","author":"C Shi","year":"2022","unstructured":"Shi, C. et al. A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease. Sci. Adv. 8, eabj2372 (2022).","journal-title":"Sci. Adv."},{"key":"70453_CR40","doi-asserted-by":"publisher","first-page":"102155","DOI":"10.1016\/j.nantod.2024.102155","volume":"55","author":"L Xing","year":"2024","unstructured":"Xing, L. et al. Orally hierarchical targeting delivery systems relieve colitis by protecting host mitochondria and modulating gut microbiota. Nano Today 55, 102155 (2024).","journal-title":"Nano Today"},{"key":"70453_CR41","doi-asserted-by":"publisher","first-page":"2000165","DOI":"10.1002\/adtp.202000165","volume":"4","author":"Z Qu","year":"2021","unstructured":"Qu, Z. et al. One-pot synthesis of pH-responsive eudragit-mesoporous silica nanocomposites enable colonic delivery of glucocorticoids for the treatment of inflammatory bowel disease. Adv. Ther. 4, 2000165 (2021).","journal-title":"Adv. Ther."},{"key":"70453_CR42","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3390\/jcm11020400","volume":"11","author":"A Ka\u0142u\u017cna","year":"2022","unstructured":"Ka\u0142u\u017cna, A., Olczyk, P. & Komosi\u0144ska-Vassev, K. The role of innate and adaptive immune cells in the pathogenesis and development of the inflammatory response in ulcerative colitis. J. Clin. Med 11, 400 (2022).","journal-title":"J. Clin. Med"},{"key":"70453_CR43","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41590-019-0415-0","volume":"20","author":"MF Neurath","year":"2019","unstructured":"Neurath, M. F. Targeting immune cell circuits and trafficking in inflammatory bowel disease. Nat. Immunol. 20, 970\u2013979 (2019).","journal-title":"Nat. Immunol."},{"key":"70453_CR44","doi-asserted-by":"publisher","first-page":"eade5041","DOI":"10.1126\/sciadv.ade5041","volume":"9","author":"L Tong","year":"2023","unstructured":"Tong, L. et al. Milk-derived extracellular vesicles protect intestinal barrier integrity in the gut-liver axis. Sci. Adv. 9, eade5041 (2023).","journal-title":"Sci. Adv."},{"key":"70453_CR45","doi-asserted-by":"publisher","first-page":"113887","DOI":"10.1016\/j.addr.2021.113887","volume":"176","author":"M Zu","year":"2021","unstructured":"Zu, M. et al. Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases. Adv. Drug Deliv. Rev. 176, 113887 (2021).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"70453_CR46","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jconrel.2021.11.026","volume":"341","author":"Y Yu","year":"2022","unstructured":"Yu, Y. et al. Coordination of rigidity modulation and targeting ligand modification on orally-delivered nanoparticles for the treatment of liver fibrosis. J. Control Release 341, 215\u2013226 (2022).","journal-title":"J. Control Release"},{"key":"70453_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05061-3","volume":"9","author":"M Yu","year":"2018","unstructured":"Yu, M. et al. Rapid transport of deformation-tuned nanoparticles across biological hydrogels and cellular barriers. Nat. Commun. 9, 2607 (2018).","journal-title":"Nat. Commun."},{"key":"70453_CR48","doi-asserted-by":"publisher","first-page":"120323","DOI":"10.1016\/j.biomaterials.2020.120323","volume":"262","author":"Y Zheng","year":"2020","unstructured":"Zheng, Y. et al. Tailored elasticity combined with biomimetic surface promotes nanoparticle transcytosis to overcome mucosal epithelial barrier. Biomaterials 262, 120323 (2020).","journal-title":"Biomaterials"},{"key":"70453_CR49","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nbt.1592","volume":"28","author":"NM Griffin","year":"2010","unstructured":"Griffin, N. M. et al. Label-free, normalized quantification of complex mass spectrometry data for proteomic analysis. Nat. Biotechnol. 28, 83\u201389 (2010).","journal-title":"Nat. Biotechnol."},{"key":"70453_CR50","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/nprot.2016.136","volume":"11","author":"S Tyanova","year":"2016","unstructured":"Tyanova, S., Temu, T. & Cox, J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat. Protoc. 11, 2301\u20132319 (2016).","journal-title":"Nat. Protoc."},{"key":"70453_CR51","doi-asserted-by":"publisher","first-page":"D1049","DOI":"10.1093\/nar\/gku1179","volume":"43","author":"GOC research","year":"2015","unstructured":"research, G. O. C. Gene ontology consortium: going forward. Nucleic Acids Res 43, D1049\u2013D1056 (2015).","journal-title":"Nucleic Acids Res"},{"key":"70453_CR52","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.4049\/jimmunol.1300133","volume":"192","author":"N Lu","year":"2014","unstructured":"Lu, N. et al. Activation of the epidermal growth factor receptor in macrophages regulates cytokine production and experimental colitis. J. Immunol. 192, 1013\u20131023 (2014).","journal-title":"J. Immunol."},{"key":"70453_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1745-7580-4-5","volume":"4","author":"JE Lattin","year":"2008","unstructured":"Lattin, J. E. et al. Expression analysis of G protein-coupled receptors in mouse macrophages. Immunome Res 4, 1\u201313 (2008).","journal-title":"Immunome Res"},{"key":"70453_CR54","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1146\/annurev.immunol.23.021704.115816","volume":"23","author":"PR Taylor","year":"2005","unstructured":"Taylor, P. R. et al. Macrophage receptors and immune recognition. Annu Rev. Immunol. 23, 901\u2013944 (2005).","journal-title":"Annu Rev. Immunol."},{"key":"70453_CR55","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1365-2567.2005.02177.x","volume":"115","author":"T Takai","year":"2005","unstructured":"Takai, T. Paired immunoglobulin-like receptors and their MHC class I recognition. Immunology 115, 433\u2013440 (2005).","journal-title":"Immunology"},{"key":"70453_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.0300-9475.2005.01534.x","volume":"61","author":"R Kokkola","year":"2005","unstructured":"Kokkola, R. et al. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand. J. Immunol. 61, 1\u20139 (2005).","journal-title":"Scand. J. Immunol."},{"key":"70453_CR57","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.atherosclerosis.2005.03.045","volume":"183","author":"M Van Eck","year":"2005","unstructured":"Van Eck, M. et al. Role of the macrophage very-low-density lipoprotein receptor in atherosclerotic lesion development. Atherosclerosis 183, 230\u2013237 (2005).","journal-title":"Atherosclerosis"},{"key":"70453_CR58","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cca.2011.08.021","volume":"413","author":"AN Seneviratne","year":"2012","unstructured":"Seneviratne, A. N., Sivagurunathan, B. & Monaco, C. Toll-like receptors and macrophage activation in atherosclerosis. Clin. Chim. Acta 413, 3\u201314 (2012).","journal-title":"Clin. Chim. Acta"},{"key":"70453_CR59","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jconrel.2020.04.013","volume":"323","author":"L Wu","year":"2020","unstructured":"Wu, L. et al. Promoting apical-to-basolateral unidirectional transport of nanoformulations by manipulating the nutrient-absorption pathway. J. Control Release 323, 151\u2013160 (2020).","journal-title":"J. Control Release"},{"key":"70453_CR60","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jconrel.2017.07.045","volume":"262","author":"L Wu","year":"2017","unstructured":"Wu, L. et al. Bioinspired butyrate-functionalized nanovehicles for targeted oral delivery of biomacromolecular drugs. J. Control Release 262, 273\u2013283 (2017).","journal-title":"J. Control Release"},{"key":"70453_CR61","doi-asserted-by":"publisher","first-page":"120233","DOI":"10.1016\/j.carbpol.2022.120233","volume":"300","author":"Y Yang","year":"2023","unstructured":"Yang, Y. et al. Linolenic acid conjugated chitosan micelles for improving the oral absorption of doxorubicin via fatty acid transporter. Carbohydr. Polym. 300, 120233 (2023).","journal-title":"Carbohydr. Polym."},{"key":"70453_CR62","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.jconrel.2022.03.056","volume":"345","author":"X Wang","year":"2022","unstructured":"Wang, X. & Zhang, W. The Janus of Protein Corona on nanoparticles for tumor targeting, immunotherapy and diagnosis. J. Control Release 345, 832\u2013850 (2022).","journal-title":"J. Control Release"},{"key":"70453_CR63","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1016\/j.xphs.2018.05.020","volume":"107","author":"FS Mozar","year":"2018","unstructured":"Mozar, F. S. & Chowdhury, E. H. Pegylation of carbonate apatite nanoparticles prevents opsonin binding and enhances tumor accumulation of gemcitabine. J. Pharm. Sci. 107, 2497\u20132508 (2018).","journal-title":"J. Pharm. Sci."},{"key":"70453_CR64","doi-asserted-by":"publisher","first-page":"120305","DOI":"10.1016\/j.biomaterials.2020.120305","volume":"260","author":"T Huo","year":"2020","unstructured":"Huo, T. et al. Versatile hollow COF nanospheres via manipulating transferrin corona for precise glioma-targeted drug delivery. Biomaterials 260, 120305 (2020).","journal-title":"Biomaterials"},{"key":"70453_CR65","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.addr.2021.01.019","volume":"174","author":"S Antimisiaris","year":"2021","unstructured":"Antimisiaris, S. et al. Overcoming barriers by local drug delivery with liposomes. Adv. Drug Deliv. Rev. 174, 53\u201386 (2021).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"70453_CR66","first-page":"539","volume":"20","author":"Y Yu","year":"2023","unstructured":"Yu, Y. et al. Increasing stiffness promotes pulmonary retention of ligand-directed dexamethasone-loaded nanoparticle for enhanced acute lung inflammation therapy. Bioact. Mater. 20, 539\u2013547 (2023).","journal-title":"Bioact. Mater."},{"key":"70453_CR67","doi-asserted-by":"publisher","first-page":"2300570","DOI":"10.1002\/smll.202300570","volume":"19","author":"R Xie","year":"2023","unstructured":"Xie, R. et al. Hsp70-targeting and size-tunable nanoparticles combine with PD-1 checkpoint blockade to treat glioma. Small 19, 2300570 (2023).","journal-title":"Small"},{"key":"70453_CR68","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1021\/acsbiomaterials.3c01704","volume":"10","author":"EC Bender","year":"2024","unstructured":"Bender, E. C., Sircar, A. J., Taubenfeld, E. K. & Suggs, L. J. Modulating lipid-polymer nanoparticles\u2019 physicochemical properties to alter macrophage uptake. ACS Biomater. Sci. Eng. 10, 2911\u20132924 (2024).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"70453_CR69","doi-asserted-by":"publisher","first-page":"eaaz4316","DOI":"10.1126\/sciadv.aaz4316","volume":"6","author":"Y Hui","year":"2020","unstructured":"Hui, Y. et al. Nanoparticle elasticity regulates phagocytosis and cancer cell uptake. Sci. Adv. 6, eaaz4316 (2020).","journal-title":"Sci. Adv."},{"key":"70453_CR70","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.pharmthera.2016.07.015","volume":"167","author":"M Pruenster","year":"2016","unstructured":"Pruenster, M., Vogl, T., Roth, J. & Sperandio, M. S100A8\/A9: from basic science to clinical application. Pharm. Ther. 167, 120\u2013131 (2016).","journal-title":"Pharm. Ther."},{"key":"70453_CR71","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1021\/acsnano.6b08193","volume":"11","author":"Y Zhu","year":"2017","unstructured":"Zhu, Y. et al. Protein corona of magnetic hydroxyapatite scaffold improves cell proliferation via activation of mitogen-activated protein kinase signaling pathway. ACS Nano 11, 3690\u20133704 (2017).","journal-title":"ACS Nano"},{"key":"70453_CR72","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1021\/acsnano.6b00053","volume":"10","author":"K Saha","year":"2016","unstructured":"Saha, K. et al. Regulation of macrophage recognition through the interplay of nanoparticle surface functionality and protein corona. ACS Nano 10, 4421\u20134430 (2016).","journal-title":"ACS Nano"},{"key":"70453_CR73","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.molp.2020.06.009","volume":"13","author":"C Chen","year":"2020","unstructured":"Chen, C. et al. TBtools: an integrative toolkit developed for interactive analyses of big biological data. Mol. Plant 13, 1194\u20131202 (2020).","journal-title":"Mol. Plant"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70453-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70453-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70453-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:04:37Z","timestamp":1773756277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70453-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70453"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70453-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2497"}}